Coexisting cancer regimes

Transformations of breast and lung cancer in the United Kingdom

Dados Bibliográficos

ID4924907
AutoresC Greco (0000-0001-7909-2451, University of Manchester, autor correspondente)
Ano2024
Volume28
Fascículo4
Páginas615-632
Data de publicação2024-07-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoHealth An Interdisciplinary Journal for the Social Study of Health Illness and Medicine (JOURNAL)
Identificadores do periódicoISSN: 1363-4593 • E-ISSN: 1461-7196
EditoraSAGE Publications Inc (PUBLISHER)
DOI10.1177/13634593231176979
PMID37218210
OpenAlexW4377564957
IdiomaEN
Referências citadas38

Using in-depth interviews with medical professionals working in the UK, I explore the coexistence of two different cancer regimes in which the different innovations for breast and lung cancer can be located. Breast cancer treatment has seen a protracted series of significant innovations in the context of an emphasis on screening that coexists with a segmentation in subtypes that has allowed targeted therapies for most patients. Lung cancer has also seen the introduction of targeted therapies; however, these can only be used for small groups of patients. Consequently, some interviewees working on lung cancer have expressed a stronger focus on increasing the number of patients undergoing surgery, as well as introducing screening also for lung cancer. As a result, a cancer regime based on the promises of targeted therapies coexists with a more traditional approach that focuses on diagnosing and treating cancers in their early stages

Breast cancer · Cancer · Family medicine · Intensive care medicine · Lung · Lung cancer · BRCA gene mutations in cancer · Cancer Genomics and Diagnostics · Global Cancer Incidence and Screening · Medicine · Internal Medicine · Oncology